Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allison Staley

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
American Journal of Obstetrics and Gynecology|February 16, 2016
The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasiaLeslie H Clark, S Allison Staley, Emma L Barber, et al.
Gynecologic Oncology|January 14, 2020
Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapyS Allison Staley, Katherine Tucker, Meredith Newton, et al.
American Journal of Cancer Research|January 8, 2021
Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancerLindsay West, Yajie Yin, Stuart R Pierce, et al.
Annals of Surgical Oncology|June 18, 2021
Contemporary Incidence of Medical Inoperability in Clinical Stage I Endometrial CancerMichelle Ertel, S Allison Staley, Tam Nguyen, et al.
Frontiers in Oncology|November 16, 2020
ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer <i>In Vitro</i>Yingao Zhang, Yu Huang, Yajie Yin, et al.
American Journal of Translational Research|September 11, 2020
SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse modelsXiaoling Zhao, Weimin Kong, Katherine Tucker, et al.
American Journal of Cancer Research|March 9, 2022
ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancerKatherine Tucker, Yajie Yin, Stuart-Allison Staley, et al.
Frontiers in Oncology|April 4, 2022
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian CancerYali Fan, Jiandong Wang, Ziwei Fang, et al.
American Journal of Cancer Research|December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancerAllison Staley, Katherine Tucker, Yajie Yin, et al.
International Journal of Molecular Sciences|August 12, 2023
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian CancerYu Huang, Yali Fan, Ziyi Zhao, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Obstetrics and Gynecology|February 16, 2016
The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasiaLeslie H Clark, S Allison Staley, Emma L Barber, et al.
Gynecologic Oncology|January 14, 2020
Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapyS Allison Staley, Katherine Tucker, Meredith Newton, et al.
American Journal of Cancer Research|January 8, 2021
Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancerLindsay West, Yajie Yin, Stuart R Pierce, et al.
Annals of Surgical Oncology|June 18, 2021
Contemporary Incidence of Medical Inoperability in Clinical Stage I Endometrial CancerMichelle Ertel, S Allison Staley, Tam Nguyen, et al.
Frontiers in Oncology|November 16, 2020
ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer <i>In Vitro</i>Yingao Zhang, Yu Huang, Yajie Yin, et al.
American Journal of Translational Research|September 11, 2020
SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse modelsXiaoling Zhao, Weimin Kong, Katherine Tucker, et al.
American Journal of Cancer Research|March 9, 2022
ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancerKatherine Tucker, Yajie Yin, Stuart-Allison Staley, et al.
Frontiers in Oncology|April 4, 2022
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian CancerYali Fan, Jiandong Wang, Ziwei Fang, et al.
American Journal of Cancer Research|December 7, 2021
Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancerAllison Staley, Katherine Tucker, Yajie Yin, et al.
International Journal of Molecular Sciences|August 12, 2023
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian CancerYu Huang, Yali Fan, Ziyi Zhao, et al.
Pageof 3